Article
Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
Oncotarget - 13 Dec 2016
Xu Huihui, Lin Aifen, Shao Xiujuan, Shi Weiwu, Zhang Yang, Yan Weihua
Abstract excerpt
Currently, clinical data for primary HPV screening alone are lacking in China. Here, we evaluate cervical cancer screening with primary HPV genotyping, as well as possible future screening strategy. Overall, high-risk HPV (hrHPV) prevalence was 18.2% among hospital-based population in Taizhou area. For cervical intraepithelial neoplasia 2 or worse (CIN2+), the sensitivity of primary hrHPV genotyping strategy and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.